Science Explorer Back to mapMap
Discussion
Company · Halifax · Canada

AGADA Biosciences

agadabio.comROR OpenAlex
Research works
10
▲ 28% vs 2018-21
Citations
103
10.3 per fractional work
Top-10% rate
19.3%
all institutions 10.0%
Open access
47%
world 40%
International
68%
world 18%
AGADA Biosciences

Not ranked overall: AGADA Biosciences is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does AGADA Biosciences work in?

In all years, 49% of research at AGADA Biosciences is in Life Sciences, 44% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (44%), Medicine (43%), Immunology and Microbiology (4%). It does 1.8× the world's share of Life Sciences.

Life Sciences: 5 fractional works · 49.4% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 44.0% of its workMolecular Biology: 3 fractional works · 29.6% of its workCell Biology: 1 fractional works · 6.2% of its workGenetics: 1 fractional works · 6.2% of its workClinical Biochemistry: 0 fractional works · 2.0% of its workImmunology and Microbiology: 0 fractional works · 3.8% of its workImmunology: 0 fractional works · 3.8% of its workNeuroscience: 0 fractional works · 1.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.6% of its workHealth Sciences: 4 fractional works · 44.3% of its workMedicine: 4 fractional works · 43.2% of its workGenetics: 1 fractional works · 11.7% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 9.8% of its workPhysiology: 1 fractional works · 9.5% of its workHematology: 0 fractional works · 4.1% of its workRehabilitation: 0 fractional works · 3.6% of its workOncology: 0 fractional works · 2.1% of its workGeriatrics and Gerontology: 0 fractional works · 1.1% of its workEpidemiology: 0 fractional works · 0.6% of its workRheumatology: 0 fractional works · 0.5% of its workVeterinary: 0 fractional works · 1.1% of its workSmall Animals: 0 fractional works · 1.1% of its workSocial Sciences: 0 fractional works · 5.0% of its workArts and Humanities: 0 fractional works · 3.3% of its workHistory and Philosophy of Science: 0 fractional works · 3.3% of its workSocial Sciences: 0 fractional works · 1.7% of its workAnthropology: 0 fractional works · 1.7% of its workPhysical Sciences: 0 fractional works · 1.2% of its workMaterials Science: 0 fractional works · 1.1% of its workPolymers and Plastics: 0 fractional works · 1.1% of its workEnvironmental Science: 0 fractional works · 0.1% of its workALL ITS WORKAGADA Biosciences10fractional works, all years
Life Sciences49%Physical Sciences1%Health Sciences44%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology444.0%
    2. Immunology and Microbiology03.8%
    3. Neuroscience01.6%
    1. Medicine443.2%
    2. Veterinary01.1%
    1. Arts and Humanities03.3%
    2. Social Sciences01.7%
    1. Materials Science01.1%
    2. Environmental Science00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from AGADA Biosciences?

The most cited paper from AGADA Biosciences is "Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping" (Paula R. Clemens, Vamshi K. Rao, Anne M. Connolly et al., 2020), with 275 citations. Next come "Genetic tool development in marine protists: emerging model organisms for experimental cell biology" (174) and "Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy" (90).

Most cited papers
#PaperReleasedCitations
1 Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping Paula R. Clemens, Vamshi K. Rao, Anne M. Connolly et al. · JAMA Neurology Open access 26 May 2020 275
2 Genetic tool development in marine protists: emerging model organisms for experimental cell biology Drahomíra Faktorová et al. · Nature Methods Open access113 authors 6 Apr 2020 174
3 Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy Christopher R. Heier, Qing Yuan Yu, Alyson A. Fiorillo et al. · Life Science Alliance Open access Feb 2019 90
4 Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin‐deficient mdx mice: proof‐of‐concept study and independent validation of efficacy Roberta Francesca Capogrosso, Paola Mantuano, Kitipong Uaesoontrachoon et al. · The FASEB Journal Open access 2 Nov 2017 61
5 Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation Catherine M. Biggs et al. · JCI Insight Open access 21 Dec 2022 31
All 24 most cited papers, with filters and sorting

Which research topics does AGADA Biosciences publish most on?

By volume in 2022-now: Muscle Physiology and Disorders, Virus-based gene therapy research, Exercise and Physiological Responses and Adipose Tissue and Metabolism.

Muscle Physiology and Di…1Muscle Physiology and Disorders: 1 fractional worksVirus-based gene therapy research: 0 fractional worksExercise and Physiological Responses: 0 fractional worksAdipose Tissue and Metabolism: 0 fractional worksMitochondrial Function and Pathology: 0 fractional worksBlood disorders and treatments: 0 fractional worksAutoimmune and Inflammat…0Autoimmune and Inflammatory Disorders Research: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional worksViral Infections and Immunology Research: 0 fractional worksAcute Myeloid Leukemia R…0Acute Myeloid Leukemia Research: 0 fractional works
Molecular BiologyGeneticsRehabilitationPhysiology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Muscle Physiology and Disorders Molecular Biology 1 works
  2. 2 Virus-based gene therapy research Genetics 0 works
  3. 3 Exercise and Physiological Responses Rehabilitation 0 works
  4. 4 Adipose Tissue and Metabolism Physiology 0 works
  5. 5 Mitochondrial Function and Pathology Molecular Biology 0 works
  6. 6 Blood disorders and treatments Genetics 0 works
  7. 7 Autoimmune and Inflammatory Disorders Research Hematology 0 works
  8. 8 RNA Interference and Gene Delivery Molecular Biology 0 works
  9. 9 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 0 works
  10. 10 Acute Myeloid Leukemia Research Hematology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.3%not open52.7%

World: 40% of research is openly available.

with international co-authors67.5%domestic only32.5%

World: 18% is written across borders.

How has AGADA Biosciences's research output changed?

Output in 2022-2025 was 28% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is AGADA Biosciences as a percentage of every work published that year, 0.0000087% in 2024.

still counting0.000050%0.00010%0.00015%AGADA Biosciences0.000020% in 20251990200020102020

Fractional works of AGADA Biosciences over all fractional works that year. How the balance of science has shifted.

Other research institutions in Halifax

All research institutions in Halifax

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about AGADA Biosciences. Posts are plain text and can be reported.